(Healthy) ageing: Focus on iodothyronines

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 13873-13892

  de Lange, Pieter ^a   Cioffi, Federica ^b   Silvestri, Elena ^b   Moreno, Maria ^b   Goglia, Fernando ^b   Lanni, Antonia ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

Author keywords

Ageing; Non genomic pathways; Thyroid; Thyroid hormone action

Indexed keywords

ADENYLATE KINASE; DEIODINASE; DIIODOTHYRONINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IODOTHYRONINE; LIOTHYRONINE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SELENOPROTEIN; SIRTUIN 1; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

AGING; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GLYCEMIC CONTROL; HEALTH STATUS; HORMONAL REGULATION; HORMONE ACTION; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; THYROID FUNCTION; TRANSCRIPTION REGULATION; TRANSGENICS;

EID: 84880172978     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140713873     Document Type: Review

References (128)

1. Yen, P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001, 81, 1079-1142.
2. Braverman, L.E.; Ingbar, S.H.; Sterling, K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J. Clin. Invest. 1970, 49, 855-864.
3. Koehrle, J. The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Rev. Endocr. Metab. Dis. 2000, 1, 49-58.
4. Silvestri, E.; Lombardi, A.; de Lange, P.; Schiavo, L.; Lanni, A.; Goglia, F.; Visser, T.J.; Moreno, M. Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E1160-E1168.
5. Engler, D.; Burger, A.G. The deiodination of the iodothyronines and of their derivatives in man. Endocr. Rev. 1984, 5, 151-184.
6. Dentice, M.; Salvatore, D. Deiodinases: The balance of thyroid hormone: Local impact of thyroid hormone inactivation. J. Endocrinol. 2011, 209, 273-282.
7. Weinberger, C.; Thompson, C.C.; Onges, E.S.; Lebo, R.; Gruol, D.J.; Evans, R.M. The c-erbA gene encodes a thyroid hormone receptor. Nature 1986, 324, 641-646.
8. Sap, J.; Munoz, A.; Damm, K.; Goldberg, Y.; Ghyadael, J.; Leutz, A.; Beug, H.; Vennstrom, B. The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 1986, 324, 635-640.
9. Lazar, M.A. Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr. Rev. 1993, 14, 348-399.
10. Hodin, R.A.; Lazar, M.A.; Chin, W.W. Differential and tissue-specific regulation of the multiple rat c-erbA mRNA species by thyroid hormone. J. Clin. Invest. 1990, 85, 101-104.
11. Strait, K.A.; Schwartz, H.L.; Perez-Castillo A.; Oppenheimer, J.H. Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J. Biol. Chem. 1990, 265, 10514-10521.
12. Moreno, M.; de Lange, P.; Lombardi, A.; Silvestri, E.; Lanni, A.; Goglia, F. Metabolic effects of thyroid hormone derivatives. Thyroid 2008, 18, 239-253.
13. Davis, P.J.; Davis, F.B. Nongenomic actions of thyroid hormone. Thyroid 1996, 6, 497-504.
14. Moeller, L.C.; Co, X.; Dumitrescu, A.M.; Seo, H.; Refetoff, S. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor β through the phosphatidylinositol 3-kinase pathway. Nucl. Recept. Signal. 2006, 4, 1-4.
15. Lanni, A.; Moreno, M.; Lombardi, A.; de Lange, P.; Silvestri, E.; Ragni, M.; Farina, P.; Baccari, G.C.; Fallahi, P.; Antonelli, A. et al. 3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J. 2005, 19, 1552-1554.
16. Irrcher, I.; Walkinshaw, D.R.; Sheehan, T.E.; Hood, D.A. Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo. J. Appl. Physiol. 2008, 104, 178-185.
17. De Lange, P.; Senese, R.; Cioffi, F.; Moreno, M.; Lombardi, A.; Silvestri, E.; Goglia, F.; Lanni, A. Rapid activation by 3,5,3′-L-triiodothyronine of adenosine 5′-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and Akt/protein kinase B signaling pathways: Relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo. Endocrinology 2008, 149, 6462-6470.
18. Lombardi, A.; de Lange, P.; Silvestri, E.; Busiello, R.A.; Lanni, A.; Goglia, F.; Moreno, M. 3,5-diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E497-E502.
19. Lanni, A.; Moreno, M.; Cioffi, M.; Goglia, F. Effect of 3,3′-diiodothyronine and 3,5-diiodothyronine on rat liver oxidative capacity. Mol. Cell. Endocrinol. 1992, 86, 143-148.
20. Lanni, A.; Moreno, M.; Lombardi, A.; Goglia, F. Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,3′-diiodo-L-thyronine. Mol. Cell. Endocrinol. 1994, 99, 89-94.
21. De Lange, P.; Cioffi, F.; Senese, R.; Moreno, M.; Lombardi, A.; Silvestri, E.; de Matteis, R.; Lionetti, L.; Mollica, M.P.; Goglia, F. et al. Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats. Diabetes 2011, 60, 2730-2739.
22. Cordeiro, A.; Souza, L.L.; Oliveira, L.S.; Faustino, L.C.; Santiago, L.A.; Bloise, F.; Ortiga-Carvalho, T.M.; Almeida, N.A.; Pazos-Moura, C.C. Thyroid hormone regulation of sirtuin 1 (SIRT1) expression and implications to integrated responses in fasted mice. J. Endocrinol. 2012, 216, 181-193.
23. Cioffi, F.; Lanni, A.; Goglia, F. Thyroid hormones, mitochondrial bioenergetics and lipid handling. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17, 402-407.
24. Cordeiro, A.; Souza, L.L.; Einicker-Lamas, M.; Pazos-Moura, C.C. Non-classic thyroid hormone signaling involved in hepatic lipid metabolism. J. Endocrinol. 2013, 216, R47-R57.
25. Mariotti, S.; Franceschi, C.; Cossarizza, A.; Pinchera, A. The ageing thyroid. Endocr. Rev. 1995, 16, 686-715.
26. Peeters, R.P. Thyroid hormones and ageing. Hormones 2008, 7, 28-35.
27. Kemnitz, J.W. Caloric restriction and ageing in nonhuman primates. ILAR J. 2011, 8, 66-77.
28. Roth, G.S.; Handy, A.M.; Mattison, J.A.; Tilmont, E.M.; Ingram, D.K.; Lane, M.A. Effects of dietary caloric restriction and ageing on thyroid hormones of rhesus monkeys. Horm. Metab. Res. 2002, 34, 378-382.
29. Gussekloo, J.; van Exel, E.; de Craen, A.J.; Meinders, A.E.; Frohlich M.; Westendorp, R.G. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004, 292, 2591-2599.
30. Atzmon, G.; Barzilai, N.; Hollowell, J.G.; Surks, M.I.; Gabriely, I. Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab. 2009, 94, 1251-1254.
31. Rozing, M.P.; Houwing-Duistermaat, J.J.; Slagboom, P.E.; Beekman, M.; Frohlich, M.; de Craen, A.J.M.; Westendorp, R.G.J.; van Heemst, D. Familial longevity is associated with decreased thyroid function. J. Clin. Endocrinol. Metab. 2010, 95, 4979-4984.
32. Brown-Borg, H.M.; Borg, K.E.; Meliska, C.J.; Bartke, A. Dwarf mice and the ageing process. Nature 1996, 384, 33.
33. Tatar, M.; Bartke, A; Antebi, A. The endocrine regulation of ageing by insulin-like signals. Science 2003, 299, 1346-1351.
34. Vergara, M.; Smith-Wheelock, M.; Harper, J.M.; Sigler, R.; Miller, J.A. Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J. Gerontol. A. Biol. Sci. Med. Sci. 2004, 59, 1244-1250.
35. Franklyn, J.A.; Sheppard, M.C.; Maisonneuve, P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 2005, 294, 71-80.
36. Cappola, A.R.; Fried, L.P.; Arnold, A.M.; Danese, M.D.; Kuller, L.H.; Burke, G.L.; Tracy, R.P.; Ladenson, P.W. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006, 295, 1033-1041.
37. Mirza, F.S.; Prestwood, K.M. Bone health and ageing: Implications for menopause. Endocrinol. Metab. Clin. North Am. 2004, 33, 741-759.
38. Yeap, B.B.; Alfonso, H.; Chubb, S.A.P.; Walsh, J.P.; Hankey, G.J.; Almeida, O.P.; Flicker, L. Higher free thyroxine levels are associated with frailty in older men. Clin. Endocrinol. 2012, 76, 741-748.
39. Murphy, E.; Gluer, C.C.; Reid, D.M.; Felsenberg, D.; Roux, C.; Eastell, R.; Williams, G.R. Thyroid function within the upper normal range is associated with reduced menopause bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J. Clin. Endocrinol. Metab. 2010, 95, 3173-3181.
40. Monfoulet, L.E.; Rabier, B.; Dacquin, R.; Anginot, A.; Photsavang, J.; Jurdic, P.; Vico, L.; Malaval, L.; Chassande, O. Thyroid hormone receptor β mediates thyroid hormone effects on bone remodeling and bone mass. J. Bone Miner. Res. 2011, 26, 2036-2044.
41. Schindhelm, R.K.; ten Boekel, E.; Heima, N.E.; van Schoor, N.M.; Simsek, S. Thyroid hormones and erythrocyte indices in a cohort of euthyroid older subjects. Eur. J. Int. Med. 2013, 24, 241-244.
42. Bremner, A.P.; Feddema, P.; Joska, D.J.; Leedman, P.J.; O'Leary, P.C.; Olynyk, J.K.; Walsh, J.P. Significant association between thyroid hormones and erythrocyte indices in euthyroid subjects. Clin. Endocrinol. 2012, 76, 304-311.
43. Donda, A.; Lemarchand-Beraud, T. Ageing alters the activity of 5′-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 1989, 124, 1305-1309.
44. Feng, X.; Jiang, Y.; Meltzer, P.; Yen, P.M. Thyroid hormones regulation of hepatic genes in vivo detected by complementary cDNA microarray. Mol. Endocrinol. 2000, 14, 947-955.
45. Clark, P.J. Biology of renal ageing in humans. Adv. Ren. Repl. Ther. 2000, 7, 11-21.
46. Visser, W.E.; Friesema, E.C.; Jansen, J.; Visser, T.J. Thyroid hormone transport by monocarboxylate transporters. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21, 223-236.
47. 4, and thyroid antibodies in the United States population (1988-1994): National health and nutrition examination survey (NHANES III). J. Clin. Endocrinol. Metab. 2002, 87, 489-499.
48. Surks, M.I.; Hollowell, J.G. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 2007, 92, 4575-4582.
49. Bremner, A.P.; Feddema, P.; Leedman, P.J.; Brown, S.J.; Beilby, J.P.; Lim, E.M.; Wilson, S.G.; O'Leary, P.C.; Walsh, J.P. Age-related changes in thyroid function: A longitudinal study of a community-based cohort. J. Clin. Endocrinol. Metab. 2012, 97, 1554-1562.
50. Waring, A.C.; Arnold, A.M.; Newman, A.B.; Buzkova, P.; Hirsch, C.; Cappola, A.R. Longitudinal changes in thyroid function in the oldest old and survival: The cardiovascular health study all-stars study. J. Clin. Endocrinol. Metab. 2012, 97, 3944-3950.
51. Hadlow, N.C.; Rothacker, K.M.; Wardrop, R.; Brown, S.J.; Lim, E.M.; Walsh, J.P. The relationship between TSH and free T4 in a large population is complex, non-linear and differs by age and gender. J. Clin. Endocrinol. Metab. 2013, doi:10.1210/jc.2012-4223.
52. Nishikawa, M.; Inada, M.; Naito, K.; Ishii, H.; Tanaka, K.; Mashio, Y.; Imura, H. Age-related changes of serum 3,3′-diiodothyronine, 3,5′-diiodothyronine, and 3,5-diiodothyronine concentrations in man. J. Clin. Endocrinol. Metab. 1991, 52, 517-522.
53. Heima, N.E.; Eekhoff, E.M.; Oosterwerff, M.M.; Lips, P.T.; van Schoor, N.M.; Simsek, S. Thryroid function and the metabolic syndrome in older persons: A population-based study. Eur. J. Endocrinol. 2012, 168, 59-65.
54. Waring, A.C.; Rodondi, N.; Harrison, S.; Kanaya, A.M.; Simonsick, E.M.; Milijkovic, I.; Satterfield, S.; Newman, A.B.; Bauer, D.C. Thyroid function and prevalent and incident metabolic syndrome in older adults: The health, ageing and body composition study. Clin. Endocrinol. 2012, 76, 911-918.
55. Larsen, P.R.; Berry, M.J. Nutrition and hormonal regulation of thyroid hormone deiodinases. Ann. Rev. Nutr. 1995, 15, 323-352.
56. Bianco, A.C.; Salvatore, D.; Gereben, B.; Berry, M.; Larsen, P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeodinases. Endocr. Rev. 2002, 23, 38-89.
57. McCann, J.C.; Ames, B.N. Adaptive dysfunction of selenoproteins from the perspective of the triage theory: Why modest selenium deficiency may increase risk of diseases of ageing. FASEB J. 2011, 25, 1793-1814.
58. Frye, R.A. Phylogenetic classification of prokaryotic and eukaryotic sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273, 793-798.
59. Sinclair, D.A.; Guarente, L. Extrachromosomal rDNA circles-A cause of ageing in yeast. Cell 1997, 91, 1033-1042.
60. Tissenbaum, J.A.; Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410, 227-230.
61. Rogina, B.; Helfand, S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 2004, 101, 15998-16003.
62. Sasaki, T.; Maier, B.; Bartke, A.; Scrable, H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 2006, 5, 413-422.
63. Oberdoerffer, P.; Michan, S.; McVay, M.; Mostoslavsky, R.; Vann, J.; Park, S.K.; Hartlerode, A.; Stegmuller, J.; Hafner, A.; Loerch, P. et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during ageing. Cell 2008, 135, 907-918.
64. Herranz, D.; Munoz-Martin, M.; Canamero, M.; Mulero, F.; Martinez-Pastor, B.; Fernandez-Capetillo, O.; Serrano, M. Sirt1 improves healthy ageing and protects from metabolic syndrome-assocoiated cancer. Nat. Commun. 2010, doi:10.1038/ncomms1001.
65. Mostoslavsky, R.; Chua, K.F.; Lombard, D.B.; Pang, W.W.; Fischer, M.R.; Gellon, L.; Liu, P.; Mostoslavsky, G.; Franco, S.; Murphy, M.M. et al. Genomic instability and ageing-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124, 315-329.
66. Sack, M.N. The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and ageing. J. Mol. Cell. Cardiol. 2012, 52, 520-525.
67. Bordone, L.; Guarente, L. Calorie restriction, SIRT1 and metabolism: Understanding longevity. Nat. Rev. Mol. Cell. Biol. 2005, 6, 298-305.
68. Sinclair, D.A. Toward an unified theory of caloric restriction and longevity regulation. Mech. Ageing Dev. 2005, 126, 987-1002.
69. Zillikens, M.C.; van Meurs, J.B.J.; Rivadeneira, F.; Amin, N.; Hofman, A.; Oostra, B.A.; Sijbrands, E.J.G.; Witteman, J.C.M.; Pols, H.A.P.; van Duijn, C.M. et al. SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 2009, 58, 2828-2834.
70. Eigarska, S.M.; Vonk, J.M.; Boezen, H.M. SIRT1 polymorphism, long-term survival and glucose tolerance in the general population. PLoS One 2013, 8, e58636.
71. Morris, B.J. Seven sirtuins for seven deadly diseases of ageing. Free Radic. Biol. Med. 2013, 56, 133-171.
72. Baur, J.A.; Ungvari, Z.; Minor, R.K.; Le Couteur, D.G.; de Cabo, R. Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Disc. 2012, 11, 443-561.
73. De Lange, P.; Moreno, M.; Silvestri, E.; Lombardi, A.; Goglia, F.; Lanni, A. Fuel economy in food-deprived skeletal muscle: Signaling pathways and regulatory mechanisms. FASEB J. 2007, 21, 3431-3441.
74. Dasgupta, B.; Ju, J.S.; Sasaki, Y.; Liu, X.; Jung, S.-R.; Higashida, K.; Linquist, D.; Milbrandt, J. The AMPK β2 subunit is required for energy homeostasis during metabolic stress. Mol. Cell. Biol. 2012, 32, 2837-2848.
75. Apfeld, J.; O'Connor, G.; McDonagh, T.; DiStefano, P.S.; Curtis, R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 2004, 18, 3004-3009.
76. Greer, E.L.; Banko, M.R.; Brunet, A. AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity. Ann. N.Y. Acad. Sci. 2009, 1170, 688-692.
77. Qjang, W.; Weiqiang, K.; Qing, Z.; Pengju, Z.; Yi, L. Ageing impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Exp. Mol. Med. 2007, 39, 535-543.
78. Reznick, R.M.; Zong, H.; Li, J.; Morino, K.; Moore, I.K.; Yu, H.J.; Liu, Z.X.; Dong, J.; Mustard, K.J.; Hawley, S.A. et al. Ageing-associated reductions in AMPK-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 2007, 5, 151-156.
79. Mulligan, J.D.; Gonzalez, A.A.; Kumar, R.; Davis, A.J.; Saupe, K.W. Ageing elevates basal adenosine monophosphate-activated protein kinase (AMPK) activity and eliminates hypoxic activation of AMPK in mouse liver. J. Gerontol. A: Biol. Sci. Med. Sci. 2005, 60, 21-27.
80. McCarty, M.F. Chronic activation of AMP-activated kinase as a strategy for slowing ageing. Med. Hypotheses 2004, 63, 334-339.
81. Knutson, M.D.; Leeuwenburgh, C. Resveratrol and novel potent activators of SIRT1: Effects on ageing and age-related diseases. Nutr. Rev. 2008, 66, 591-596.
82. Bass, T.M.; Weinkove, D.; Houthoofd, K.; Gems, D.; Partridge, L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech. Ageing Dev. 2007, 128, 546-601.
83. Barger, J.L.; Kayo, T.; Vann, J.M.; Arias, E.B.; Wang, J.; Hacker, T.A.; Wang, Y.; Raederstorff, D.; Morrow, J.D.; Leeuwenburgh, C. et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards ageing parameters in mice. PLoS One 2008, 3, e2264.
84. Agarwal, B.; Baur J.A. Resveratrol and life extension. Ann. N. Y. Acad. Sci. 2011, 1215, 138-143.
85. Price, N.L.; Gomes, A.P.; Ling, A.J.Y.; Duarte, F.V.; Martin-Montalvo, A.; North, B.J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J.S. et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012, 15, 675-690.
86. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127, 1109-1122.
87. Zang, M.; Xu, S.; Maitland-Toolan, K.A.; Zuccolo, A.; Hou, X.; Jiang, B.; Wierzbicki, M.; Verbeuren, T.J.; Cohen, R.A. Polyphenols stimulate AMP-activated kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL-receptor deficient mice. Diabetes 2006, 55, 2180-2191.
88. Park, C.E.; Kim, M.J.; Lee, J.H.; Min, B.I.; Bae, H.; Choe, W.; Kim, S.; Ha, J. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med. 2007, 39, 222-229.
89. Bottner, M.; Christoffel, J.; Rimoldi, G.; Wuttke, W. Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitary-thyroid axis. Exp. Clin. Endocrinol. Diabetes 2006, 114, 82-90.
90. Sebai, H.; Hovsépian, S.; Ristorcelli, E.; Aouani, E.; Lombardo, D.; Fayet, G. Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5. Thyroid 2010, 20, 195-203.
91. Akieda-Asai, S.; Zaima, N.; Ikegami, N.; Kahyo, T.; Yao, I.; Hatanaka, T.; Iemura, S.-I.; Sugiyama, R.; Yokozeki, T.; Eishi, Y. et al. SIRT1 regulates thyroid-stimulating hormone release by enhancing PIP5Kγ activity through deacetylation of specific lysine residues in mammals. PLoS One 2010, 5, e11755.
92. Lombardi, A.; Silvestri, E.; Cioffi, F.; Senese, R.; Lanni, A.; Goglia, F.; de Lange, P.; Moreno, M. Defining the transcriptomic and proteomic profiles of rat ageing skeletal muscle by the use of a cDNA array, 2D-and Blue native-PAGE approach. J. Proteomics 2009, 72, 708-721.
93. Nabben, M.; Hoeks, J.; Briedé, J.J.; Glatz, J.E.; Moonen-Kornips, E.; Hesselink, M.K.; Schrauwen, P. The effect of UCP3 overexpression on mitochondrial ROS production in skeletal muscle of young versus aged mice. FEBS Lett. 2008, 582, 4147-4152.
94. Lombardi, A.; Busiello, R.A.; Napolitano, L.; Cioffi, F.; Moreno, M.; de Lange, P.; Silvestri, E.; Lanni, A.; Goglia, F. UCP3 translocates lipid hydroperoxide and mediates lipid hydroperoxide-dependent mitochondrial uncoupling. J. Biol. Chem. 2010, 285, 16599-16605.
95. Videla, L.A.; Fernandez, V.; Cornejo, P.; Vargas, R. Metabolic basis for thyroid hormone liver preconditioning: Upregulation of AMP-activated protein kinase signaling. Sci. World J. 2012, 2012, 4756751-47567510.
96. Fernandez, V.; Castillo, I.; Tapia, G.; Romanque, P.; Uribe-Echevarria, S.; Uribe, M.; Cartier-Ugarte, D.; Santander, G.; Vial, M.T.; Videla, L.A. Thyroid hormone preconditioning: Protection against ischemia-reperfusion liver injury in the rat. Hepatology 2007, 45, 170-177.
97. Pantos, C.I.; Malliopoulou, V.A.; Mourouzis, I.S.; Karamanoli, E.P.; Paizis, I.A.; Steimberg, N.; Varonos, D.D.; Cokkinos, D.V. Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 2002, 12, 325-329.
98. Li, F.; Lu, S.; Zhu, R.; Zhou, Z.; Ma, L.; Cai, L.; Liu, Z. Heme-oxygenase-1 is induced by thyroid hormone and involved in thyroid hormone preconditioning-induced protection against renal warm ischemia in rat. Mol. Cell. Endocrinol. 2011, 339, 54-62.
99. Wojtovich, A.P.; Nadtochiy, S.M.; Brookes, P.S.; Nehrke, K. Ischemic preconditioning: The role of mitochondrial and ageing. Exp. Gerontol. 2012, 47, 1-7.
100. Avogaro, A.; Vigili de Kreutzenberg, A.; Fadini, G.P. Insulin signaling and life span. Pflug. Arch. 2010, 459, 301-314.
101. Brenta, G. Why can insulin resistance be a natural consequence of thyroid dysfunction? J. Thyroid Res. 2011, 2011, 1528501-1528509.
102. Peeters, R.P.; van der Deure, W.M.; van den Beld, A.W.; van Toor, H.; Lamberts, S.W.; Janssen, J.A.; Uitterlinden, A.G.; Visser, T.J. The Asp727Glu polymorphism in the TSH receptor is associated with insulin resistance in healthy elderly men. Clin. Endocrinol. 2007, 66, 808-815.
103. Peeters, R.P.; van den Beld, A.W.; van Toor, H.; Uitterlinden, A.G.; Janssen, J.A.; Lamberts, S.W., Visser, T.J. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J. Clin. Endocrinol. Metab. 2005, 90, 256-263.
104. + metabolism and SIRT1 activity. Nature 2009, 458, 1056-1060.
105. Hou, X.; Xu, S.; Maitland-Toolan, K.A.; Sato, K.; Jiang, B.; Ido, Y.; Lan, F.; Walsh, K.; Wierzbicki, M.; Verbeuren, T.J. et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activating protein kinase. J. Biol. Chem. 2008, 283, 20015-20026.
106. Jager, S.; Handschin, C.; St Pierre J.; Spiegelman, B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylaiton of PGC-1alpha. Proc. Natl. Acad. Sci. USA 2007, 104, 12017-12022.
107. Ponugoti, B.; Kim, D.-H.; Xiao, Z.; Smith, Z.; Miao, J.; Zang, M.; Wu, S.-Y.; Chiang, C.-M.; Veenstra, T.D.; Kemper, J.K. SIRT1 deacetylates and inhibits SREBP-1c activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 2010, 285, 33959-33970.
108. Greer, E.L.; Oskoui, P.R.; Banko, M.R.; Maniar, J.M.; Gygi, M.P.; Gygi, S.P.; Brunet, A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription. J. Biol. Chem. 2007, 282, 30107-30119.
109. Brunet, A.; Sweeney, L.B.; Sturgill, J.F.; Chua, K.F.; Greer, P.L.; Lin, Y.; Tran, H.; Ross, S.E.; Mostoslavsky, R.; Cohen, H.Y. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303, 2011-2015.
110. +? Pharm. Rev. 2012, 64, 166-187.
111. Moreno, M.; Lombardi, A.; Beneduce, L.; Silvestri, E.; Pinna, G.; Goglia, F.; Lanni, A. Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself? Endocrinology 2002, 143, 504-510.
112. Li, Y.; Xu, S.; Giles, A.; Nakamura, K.; Lee, J.W.; Hou, X.; Donmez, G.; Li, J.; Luo, Z.; Walsh, K. et al. Hepatic overexpression of SIT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J. 2011, 25, 1664-1679.
113. Feige, J.N.; Lagouge, M.; Canto, C.; Strehle, A.; Houten, S.M.; Milne, J.C.; Lambert, P.D.; Mataki, C.; Elliott, P.J.; Auwerx, J. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008, 8, 347-358.
114. Purushotham, A.; Xu, Q.; Li, X. Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding. FASEB J. 2012, 26, 656-667.
115. Beck Jorgensen, S.; O'Neill, H.M.; Hewitt, K.; Kemp, B.E.; Steinberg, G.R. Reduced AMPK-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 2009, 52, 2395-2404.
116. Jun, M.; Perkovic, I.; Cass, A. Intensive glycemic control and renal outcome. Contrib. Nephrol. 2011, 170, 196-208.
117. Maeda, S.; Koya, D.; Araki, S.; Babazono, T.; Umezono, T.; Toyoda, M.; Kawai, K.; Imanishi, M.; Uzu, T.; Suzuki, D. et al. Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes. Clin. Exp. Nephrol. 2011, 15, 381-390.
118. Shang, G.; Gao, P.; Zhao, Z.; Chen, Q.; Jiang, T.; Zhang, N.; Li, H. 3,5-diiodo-L-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta 2013, 1832, 674-684.
119. Hashimoto, K.; Cohen, R.N.; Yamada, M.; Markan, K.R.; Monden, T.; Satoh, T.; Mori, M.; Wondisford, F.E. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J. Biol. Chem. 2006, 281, 295-302.
120. Thakran, S.; Sharma, P.; Attia, R.R.; Hori, R.T.; Deng, X.; Elam, M.B.; Park, E.A. Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone. J. Biol. Chem. 2013, 288, 807-818.
121. Frenzel, M.; Rommelspacher, H.; Sugawa, M.D.; Dencher, N.A. Ageing alters the supramolecular architecture of OxPhos complexes in rat brain cortex. Exp. Gerontol. 2010, 45, 563-572.
122. Gomez, L.A.; Monette, J.S.; Chavez, J.D.; Maier, C.S.; Hagen, T.M. Supercomplexes of the mitochondrial electron transport chain decline in the ageing rat heart. Arch. Biochem. Biophys. 2009, 490, 30-35.
123. Gates, A.C.; Bernal-Mizrachi, C.; Chinault, S.L.; Feng, C.; Schneider, J.G.; Coleman, T.; Malone, J.P.; Townsend, R.R.; Chakravarty, M.V.; Semenkovich, C.F. Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. Cell Metab. 2007, 6, 497-505.
124. Speakman, J.R.; Talbot, D.A.; Selman, C.; Snart, C.; McLaren, J.S.; Redman, P.; Krol, E.; Jackson, D.M.; Johnson, M.S.; Brand, M.D. Uncoupled and surviving: Individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 2004, 3, 87-95.
125. Amara, C.E.; Shankland, E.G.; Jubrias, S.A.; Marcinek, D.J.; Kushmerick, M.J.; Conley, K.E. Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo. Proc. Natl. Acad. Sci. USA 2007, 104, 1057-1062.
126. Kerner, J.; Turkaly, P.J.; Minkler, P.E.; Hoppel, C.L. Ageing skeletal muscle mitochondria in the rat: Decreased uncoupling protein-3 content. Am. J. Physiol. Endocrinol. Metab. 2001, 281, E1054-E1062.
127. Lanni, A.; Beneduce, L.; Lombardi, A.; Moreno, M.; Boss, O.; Muzzin, P.; Giacobino, J.P.; Goglia, F. Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle. FEBS Lett. 1999, 444, 250-254.
128. De Lange, P.; Lanni, A.; Beneduce, L.; Moreno, M.; Lombardi, A.; Silvestri, E.; Goglia, F. Uncoupling protein-3 is a molecular determinant for the regulation of resting metabolic rate by thyroid hormone. Endocrinology 2001, 142, 3414-3420.